Pancreatitis as immune‐related adverse event during pembrolizumab therapy for multiple lung metastases from renal pelvic cancer

INTRODUCTION: Pembrolizumab administration has become the standard of care for patients with urothelial carcinoma, though a variety of adverse events have been reported. Presented here is a rare case of pancreatitis that occurred as an immune‐related adverse event. CASE PRESENTATION: An 81‐year‐old...

Descripción completa

Detalles Bibliográficos
Autores principales: Kokura, Kazuki, Watanabe, Jun, Takuma, Takaaki, Yokozeki, Hitoshi, Uketa, Shoko, Uemura, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622221/
https://www.ncbi.nlm.nih.gov/pubmed/37928307
http://dx.doi.org/10.1002/iju5.12633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622221/
https://www.ncbi.nlm.nih.gov/pubmed/37928307
http://dx.doi.org/10.1002/iju5.12633

Ejemplares similares